These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8163669

  • 21. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC, Dahlmans VE, van Gorp PJ, Breuer ML, Mol MJ, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [Abstract] [Full Text] [Related]

  • 22. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
    Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G.
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
    [Abstract] [Full Text] [Related]

  • 23. Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet.
    van Diepen JA, Vroegrijk IO, Berbée JF, Shoelson SE, Romijn JA, Havekes LM, Rensen PC, Voshol PJ.
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1099-107. PubMed ID: 21862721
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
    Boisfer E, Lambert G, Atger V, Tran NQ, Pastier D, Benetollo C, Trottier JF, Beaucamps I, Antonucci M, Laplaud M, Griglio S, Chambaz J, Kalopissis AD.
    J Biol Chem; 1999 Apr 23; 274(17):11564-72. PubMed ID: 10206963
    [Abstract] [Full Text] [Related]

  • 25. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.
    Shachter NS.
    Curr Opin Lipidol; 2001 Jun 23; 12(3):297-304. PubMed ID: 11353333
    [Abstract] [Full Text] [Related]

  • 26. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
    Fruchart-Najib J, Baugé E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):397-404. PubMed ID: 15178420
    [Abstract] [Full Text] [Related]

  • 28. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL.
    J Clin Invest; 1995 Dec 25; 96(6):2555-68. PubMed ID: 8675619
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov 25; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 30. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
    den Boer MA, Berbée JF, Reiss P, van der Valk M, Voshol PJ, Kuipers F, Havekes LM, Rensen PC, Romijn JA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 25; 26(1):124-9. PubMed ID: 16269669
    [Abstract] [Full Text] [Related]

  • 31. Endogenous hypertriglyceridemia intensifies the course of cerulein-induced pancreatitis in rat: relation with changes in the VLDL composition.
    Ponzo O, Schreier L, Resnik R, Negri G, Scacchi P, Cresta MA, Wikinski R.
    Ann Nutr Metab; 2006 Jan 25; 50(1):37-44. PubMed ID: 16276074
    [Abstract] [Full Text] [Related]

  • 32. Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only mice.
    Conde-Knape K, Okada K, Ramakrishnan R, Shachter NS.
    J Lipid Res; 2004 Dec 25; 45(12):2235-44. PubMed ID: 15342689
    [Abstract] [Full Text] [Related]

  • 33. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle.
    Pulawa LK, Jensen DR, Coates A, Eckel RH.
    J Lipid Res; 2007 Jan 25; 48(1):145-51. PubMed ID: 17018885
    [Abstract] [Full Text] [Related]

  • 34. Plasma apolipoprotein CII levels in hypertriglyceridemia.
    Ishibashi S, Murase T, Takahashi K, Mori N, Kawakami M, Takaku F.
    Metabolism; 1986 Aug 25; 35(8):781-5. PubMed ID: 3736415
    [Abstract] [Full Text] [Related]

  • 35. Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.
    Ćwiklińska A, Gliwińska A, Senderowska Z, Kortas-Stempak B, Kuchta A, Dąbkowski K, Jankowski M.
    Chem Phys Lipids; 2016 Feb 25; 195():63-70. PubMed ID: 26756862
    [Abstract] [Full Text] [Related]

  • 36. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML.
    J Clin Invest; 1986 Feb 25; 77(2):520-7. PubMed ID: 3944267
    [Abstract] [Full Text] [Related]

  • 37. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S, Homma Y, Sakane H, Kobayashi T, Ozawa H, Okajima Y.
    Tokai J Exp Clin Med; 1996 Dec 25; 21(4-6):165-9. PubMed ID: 9300976
    [Abstract] [Full Text] [Related]

  • 38. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 39. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
    Ding Y, Wang Y, Zhu H, Fan J, Yu L, Liu G, Liu E.
    Transgenic Res; 2011 Aug 01; 20(4):867-75. PubMed ID: 21120692
    [Abstract] [Full Text] [Related]

  • 40. Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size.
    Zsigmond E, Scheffler E, Forte TM, Potenz R, Wu W, Chan L.
    J Biol Chem; 1994 Jul 22; 269(29):18757-66. PubMed ID: 8034629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.